Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

Despite drastic improvement in overall survival for pediatric patients with cancer, those with osteosarcoma have stable rates of survival since the 1980s. This project evaluates the effect of several variables on survival after first recurrence in patients with osteosarcoma.

[1]  Ling Yu,et al.  LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93 , 2020, Cancer management and research.

[2]  Jacob G. Scott,et al.  223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy , 2020, ESMO Open.

[3]  Qi Jiang,et al.  Survival-associated alternative splicing signatures in soft tissue sarcomas , 2020, Annals of translational medicine.

[4]  Z. Hou,et al.  Effectiveness of electroacupuncture for pain after osteosarcoma post surgery , 2019, Medicine.

[5]  V. Lewis,et al.  Current and future therapeutic approaches for osteosarcoma , 2018, Expert review of anticancer therapy.

[6]  K. S. Hall,et al.  Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial , 2016, The Lancet. Oncology.

[7]  K. Janeway,et al.  The case for informative phase 2 trials in osteosarcoma. , 2016, The Lancet Oncology.

[8]  P. Meltzer,et al.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  N. Jaffe,et al.  Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review , 2014, British Journal of Cancer.

[10]  L. Constine,et al.  Long‐term cause‐specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: A population‐based study of 28,844 patients , 2014, Cancer.

[11]  P. Lin,et al.  What Are the Factors That Affect Survival and Relapse After Local Recurrence of Osteosarcoma? , 2014, Clinical orthopaedics and related research.

[12]  Paul A Meyers,et al.  Outcome for adolescent and young adult patients with osteosarcoma , 2012, Cancer.

[13]  M. van Glabbeke,et al.  Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. , 2011, European journal of cancer.

[14]  E. Kleinerman,et al.  Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group , 2010, Clinical Cancer Research.

[15]  S. Bielack,et al.  Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  N. Daw,et al.  Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience , 2008, Cancer.

[17]  Paul A Meyers,et al.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. van Glabbeke,et al.  Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. , 2007, Journal of the National Cancer Institute.

[19]  B. Crompton,et al.  Survival after recurrence of osteosarcoma: A 20‐year experience at a single institution , 2006, Pediatric blood & cancer.

[20]  S. Ferrari,et al.  Late Relapse in Osteosarcoma , 2006, Journal of pediatric hematology/oncology.

[21]  A. Petrilli,et al.  Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Huvos,et al.  Treatment of osteosarcoma at first recurrence after contemporary therapy , 2005, Cancer.

[23]  S. Ferrari,et al.  Resection of recurrent pulmonary metastases in patients with osteosarcoma , 2005, Cancer.

[24]  M. Semik,et al.  Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Ferrari,et al.  Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy , 2005, Acta oncologica.

[26]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[27]  W. Winkelmann,et al.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Ferrari,et al.  Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[30]  A. Huvos,et al.  Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  A. Huvos,et al.  Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Shuster,et al.  Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. , 1991, Clinical orthopaedics and related research.

[33]  P. Holland,et al.  Discrete Multivariate Analysis. , 1976 .

[34]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[35]  O. Borgan.  The Statistical Analysis of Failure Time Data (2nd Ed.). John D. Kalbfleisch and Ross L. Prentice , 2003 .